TABLE 1.

Proportion of Patients With Detected Antibodies in the ELEMENT 2 Trial

PopulationVisitBasaglar Patients With Detected Antibodies (n [%])Lantus Patients With Detected Antibodies (n [%])
Full analysis setBaseline20 (5.5)13 (3.6)
Week 24 overall56 (15.3)40 (11.0)
Week 24 LOCF30 (8.2)22(6.0)
Previous Lantus patientsBaseline10 (6.6)6 (4.4)
Week 24 overall29 (19.2)11 (7.9)
Week 24 LOCF13 (8.6)5 (3.6)
Previously insulin-naive patientsBaseline10 (4.7)7 (3.1)
Week 24 overall27 (12.6)29 (12.8)
Week 24 LOCF17 (7.9)17 (7.5)